Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$3,308 Mln
Revenue (TTM)
$343 Mln
Net Profit (TTM)
$0 Mln
ROE
0.1 %
ROCE
-- %
P/E Ratio
22.4
P/B Ratio
2.3
Industry P/E
30.29
EV/EBITDA
16.5
Div. Yield
5.1 %
Debt to Equity
0.6
Book Value
$--
EPS
$3.2
Face value
--
Shares outstanding
46,693,700
CFO
$1,926.73 Mln
EBITDA
$2,374.94 Mln
Net Profit
$1,176.14 Mln
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
---|---|---|---|---|---|---|---|
National Health Investors (NHI)
| 4.0 | -0.1 | -1.7 | 8.0 | 6.6 | 3.9 | 1.0 |
BSE Sensex
| 4.7 | 1.2 | 6.5 | 6.1 | 16.5 | 18.6 | 11.4 |
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
Company
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
---|---|---|---|---|---|---|---|
National Health Investors (NHI)
| 23.9 | 7.0 | -9.1 | -11.7 | -8.7 | 13.7 | 5.9 |
S&P Small-Cap 600
| 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 | -9.7 |
BSE Sensex
| 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 | 5.9 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
---|---|---|---|---|---|---|---|---|
National Health Investors (NHI)
|
71.9 | 3,307.8 | 343.0 | 141.2 | 56.9 | 10.7 | 22.4 | 2.3 |
9.2 | 9,448.7 | 1,575.0 | 470.0 | 115.0 | 4.8 | 25.7 | 1.1 | |
19.1 | 11,575.4 | 6,288.5 | 663.2 | 83.9 | 5.1 | 20.8 | 1.0 | |
42.7 | 9,787.0 | 1,077.9 | 385.9 | 44.5 | 13.7 | 25.3 | 3.4 | |
46.9 | 12,749.5 | 1,550.8 | 775.3 | 73.6 | 17.8 | 16.4 | 3.0 | |
15.7 | 10,947.5 | -- | -- | -- | -- | 16.2 | 1.6 | |
120.3 | 12,296.0 | 2,214.4 | 422.4 | 27.4 | 34.5 | 29.2 | 10.0 | |
37.1 | 10,996.5 | 1,084.9 | 448.0 | 62.7 | 9.7 | 23 | 2.3 | |
17.3 | 11,879.9 | 2,796.8 | 279.1 | 17.1 | 3 | 41.7 | 1.5 | |
20.2 | 7,000.6 | 1,921.8 | 317.9 | 60.1 | 4.6 | 21.3 | 1.1 |
Incorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and... discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals. Read more
President, CEO & Director
Mr. D. Eric Mendelsohn
Executive VP of Finance, CFO & Treasurer
Mr. John L. Spaid
Headquarters
Murfreesboro, TN
Website
The total asset value of National Health Investors Inc (NHI) stood at $ 3,305 Mln as on 31-Mar-25
The share price of National Health Investors Inc (NHI) is $71.90 (NYSE) as of 23-Jun-2025 13:44 EDT. National Health Investors Inc (NHI) has given a return of 6.62% in the last 3 years.
National Health Investors Inc (NHI) has a market capitalisation of $ 3,308 Mln as on 20-Jun-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of National Health Investors Inc (NHI) is 2.32 times as on 20-Jun-2025, a 107% premium to its peers’ median range of 1.12 times.
The P/E ratio of National Health Investors Inc (NHI) is 22.42 times as on 20-Jun-2025, a 26% discount to its peers’ median range of 30.29 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the National Health Investors Inc (NHI) and enter the required number of quantities and click on buy to purchase the shares of National Health Investors Inc (NHI).
Incorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
The CEO & director of Mr. D. Eric Mendelsohn. is National Health Investors Inc (NHI), and CFO & Sr. VP is Mr. John L. Spaid.
There is no promoter pledging in National Health Investors Inc (NHI).
Some of the close peers are:
Company | Market Cap($ Mln) |
---|---|
1,275
|
|
1,227
|
|
1,185
|
|
1,161
|
|
1,102
|
|
1,095
|
|
985
|
|
945
|
|
693
|
National Health Investors Inc. (NHI) | Ratios |
---|---|
Return on equity(%)
|
10.74
|
Operating margin(%)
|
56.91
|
Net Margin(%)
|
41.17
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of National Health Investors Inc (NHI) was $0 Mln.